{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:20:21Z","timestamp":1788942021767,"version":"build-2803163510"},"reference-count":127,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3UL1TR002378-05S2"],"award-info":[{"award-number":["3UL1TR002378-05S2"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["COBB23B0"],"award-info":[{"award-number":["COBB23B0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["WU23GE0"],"award-info":[{"award-number":["WU23GE0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Endocrinology"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Cystic fibrosis-related bone disease (CFBD) is a common endocrinopathy in people living with cystic fibrosis (CF) that is complex and multifactorial in origin. People with CF experience high rates of progressive bone density loss and increased fracture risk. Focus on prevention and treatment of CFBD is of increasing importance in a now aging CF population. This review will discuss current practices in CFBD, gaps in knowledge, and potential future studies with the goal of advancing the clinical care of patients with CFBD.<\/jats:p>","DOI":"10.1177\/20420188251328210","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T13:51:55Z","timestamp":1743688315000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6304-6878","authenticated-orcid":false,"given":"Crystal","family":"Cobb","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malinda","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-5853","authenticated-orcid":false,"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, 101 Woodruff Circle, WMRB 1301, Atlanta, GA 30322, USA"},{"name":"Department of Medicine, Atlanta VA Medical Center, Decatur, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.01.009"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.02.009"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10666"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-9-125"},{"key":"e_1_3_4_6_2","first-page":"283","article-title":"Bone involvement in young adults with cystic fibrosis\u2014a Portuguese cohort","volume":"46","author":"Garcia S","year":"2021","unstructured":"Garcia S, Terroso G, Amorim A, et al. Bone involvement in young adults with cystic fibrosis\u2014a Portuguese cohort. Acta Reumatol Port 2021; 46: 283\u2013285.","journal-title":"Acta Reumatol Port"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-019-04893-z"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.05.009"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.08.017"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjae139"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2016.06.004"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-3-199802010-00004"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1629"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcp.0000142923.00683.d2"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25375"},{"key":"e_1_3_4_16_2","first-page":"47","article-title":"Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis","volume":"102","author":"O\u2019Reilly R","year":"2009","unstructured":"O\u2019Reilly R, Fitzpatrick P, Leen G, et al. Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis. Ir Med J 2009; 102: 47\u201349.","journal-title":"Ir Med J"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.08.018"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23894"},{"key":"e_1_3_4_19_2","unstructured":"Cystic Fibrosis Foundation. Bone disease in CF clinical care guidelines https:\/\/www.cff.org\/medical-professionals\/bone-disease-cf-clinical-care-guidelines (2021 accessed 15 August 2024)."},{"key":"e_1_3_4_20_2","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","volume":"1","author":"Jeffery TC","year":"2023","unstructured":"Jeffery TC, Chang AB, Conwell LS. Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database Syst Rev 2023; 1: CD002010.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.075887"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2004.05.021"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00050204"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.01.039"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2010.05.001"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2144LE"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.611921"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080098"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.2478\/ams-2013-0011"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.08.011"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030479"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602582"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.48.6.589"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-014-0572-z"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.6.9712089"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(03)00087-0"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2017.06.011"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3343-3"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/126.suppl_4.1159S"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2069176"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2015.09.013"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/86.5.1694"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/218691"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03216.x"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.08.022"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/73.3.602"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2023.106332"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200403-387OC"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3050"},{"key":"e_1_3_4_50_2","first-page":"100278","article-title":"Cystic fibrosis related diabetes (CFRD) prognosis","volume":"26","author":"Sandouk Z","year":"2021","unstructured":"Sandouk Z, Khan F, Khare S, et al. Cystic fibrosis related diabetes (CFRD) prognosis. J Clin Transl Endocrinol 2021; 26: 100278.","journal-title":"J Clin Transl Endocrinol"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.08.016"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2016.09.010"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04484.x"},{"key":"e_1_3_4_54_2","first-page":"100304","article-title":"Bone metabolism and incretin hormones following glucose ingestion in young adults with pancreatic insufficient cystic fibrosis","volume":"30","author":"Lei WS","year":"2022","unstructured":"Lei WS, Kilberg MJ, Zemel BS, et al. Bone metabolism and incretin hormones following glucose ingestion in young adults with pancreatic insufficient cystic fibrosis. J Clin Transl Endocrinol 2022; 30: 100304.","journal-title":"J Clin Transl Endocrinol"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-022-00190-4"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-019-03019-x"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1508"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2008.05.095"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.11.011"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199910)28:4<248::AID-PPUL3>3.0.CO;2-N"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02278-2023"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0341-0"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70172-6"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.9.798"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2012.03.008"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.08.013"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.051106"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2004.05.009"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2024.07.013"},{"key":"e_1_3_4_70_2","first-page":"100288","article-title":"CF and male health: sexual and reproductive health, hypogonadism, and fertility","volume":"27","author":"Naz Khan F","year":"2022","unstructured":"Naz Khan F, Mason K, Roe AH, et al. CF and male health: sexual and reproductive health, hypogonadism, and fertility. J Clin Transl Endocrinol 2022; 27: 100288.","journal-title":"J Clin Transl Endocrinol"},{"key":"e_1_3_4_71_2","first-page":"100223","article-title":"Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density","volume":"20","author":"Wu M","year":"2020","unstructured":"Wu M, Hunt WR, Putman MS, et al. Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density. J Clin Transl Endocrinol 2020; 20: 100223.","journal-title":"J Clin Transl Endocrinol"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-007-0010-4"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.109.5.1176"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.2.476"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13269"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(11)60004-0"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-693X(09)74088-6"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.4158\/GL-2020-0524SUPPL"},{"key":"e_1_3_4_79_2","unstructured":"International Osteoporosis Foundation. Diagnosis other diagnostic tools https:\/\/www.osteoporosis.foundation\/health-professionals\/diagnosis (2019 accessed 15 August 2024)."},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab028"},{"key":"e_1_3_4_81_2","first-page":"2652403","article-title":"Celiac disease in patients with cystic fibrosis-related bone disease","volume":"2017","author":"Putman MS","year":"2017","unstructured":"Putman MS, Haagensen A, Neuringer I, et al. Celiac disease in patients with cystic fibrosis-related bone disease. Case Rep Endocrinol 2017; 2017: 2652403.","journal-title":"Case Rep Endocrinol"},{"key":"e_1_3_4_82_2","first-page":"2652403","article-title":"Hypogonadism in a man with cystic fibrosis and an unusually low serum testosterone: a cautionary tale","volume":"2017","author":"Lertdetkajorn K","year":"2017","unstructured":"Lertdetkajorn K, Cobb C, Kapolka RJ, et al. Hypogonadism in a man with cystic fibrosis and an unusually low serum testosterone: a cautionary tale. AACE Clin Case Rep 2017; 2017: 2652403.","journal-title":"AACE Clin Case Rep"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-06290-x"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2015.05.016"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56114-1"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11050484"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07179-1"},{"key":"e_1_3_4_88_2","first-page":"567","article-title":"The use of machine learning techniques to predict diabetes in patients with cystic fibrosis","volume":"294","author":"Bogovic T","year":"2022","unstructured":"Bogovic T, Kokol P, Zavrsnik J, et al. The use of machine learning techniques to predict diabetes in patients with cystic fibrosis. Stud Health Technol Inform 2022; 294: 567\u2013568.","journal-title":"Stud Health Technol Inform"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(24)01531-5"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.01.002"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2008.02.020"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.3.2002051"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.4.314"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200307-1049OC"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0608"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2002.002568"},{"key":"e_1_3_4_97_2","first-page":"270","article-title":"Oral bisphosphonates improve bone mineral density in adults with cystic fibrosis","volume":"98","author":"Cawood TJ","year":"2005","unstructured":"Cawood TJ, McKenna MJ, Gallagher CG, et al. Oral bisphosphonates improve bone mineral density in adults with cystic fibrosis. Ir Med J 2005; 98: 270\u2013273.","journal-title":"Ir Med J"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2011.07.007"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70064-X"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03434.x"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"e_1_3_4_102_2","first-page":"893589","article-title":"Evaluation of teriparatide for treatment of osteoporosis in four patients with cystic fibrosis: a case series","volume":"2014","author":"Siwamogsatham O","year":"2014","unstructured":"Siwamogsatham O, Stephens K, Tangpricha V. Evaluation of teriparatide for treatment of osteoporosis in four patients with cystic fibrosis: a case series. Case Rep Endocrinol 2014; 2014: 893589.","journal-title":"Case Rep Endocrinol"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2022.04.018"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607948"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809493"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807120"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1986OC"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100690"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02153-2022"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13092907"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2017.10"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25781"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202312-1065OC"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2024.02.005"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa890"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.02.003"},{"key":"e_1_3_4_117_2","unstructured":"Cystic Fibrosis Foundation. 2023 Patient registry annual report. Bethesda MA: Cystic Fibrosis Foundation https:\/\/www.cff.org\/media\/34491\/download (2024 accessed 11 October 2024)."},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.2.539"},{"key":"e_1_3_4_119_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/GME.0000000000002155","article-title":"Menopause in people with cystic fibrosis","volume":"30","author":"Prochownik K","year":"2023","unstructured":"Prochownik K, Jain R, Taylor-Cousar JL, et al. Menopause in people with cystic fibrosis. Menopause 2023; 30: 401\u2013405.","journal-title":"Menopause"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2236"},{"key":"e_1_3_4_121_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05900-y"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"e_1_3_4_123_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00192"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22967"},{"key":"e_1_3_4_125_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106126"},{"key":"e_1_3_4_126_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00018712"},{"key":"e_1_3_4_127_2","first-page":"4358","article-title":"Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism","volume":"81","author":"Katznelson L","year":"1996","unstructured":"Katznelson L, Finkelstein JS, Schoenfeld DA, et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996; 81: 4358\u20134365.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_4_128_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308836"}],"container-title":["Therapeutic Advances in Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188251328210","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20420188251328210","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188251328210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:36:48Z","timestamp":1777592208000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20420188251328210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":127,"alternative-id":["10.1177\/20420188251328210"],"URL":"https:\/\/doi.org\/10.1177\/20420188251328210","relation":{},"ISSN":["2042-0188","2042-0196"],"issn-type":[{"value":"2042-0188","type":"print"},{"value":"2042-0196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"article-number":"20420188251328210"}}